Ceftriaxone and Encephalitis viral - a phase IV clinical study of FDA data

Summary:

Encephalitis viral is reported as a side effect among people who take Ceftriaxone (ceftriaxone sodium), especially for people who are female, 0-1 old, have been taking the drug for < 1 month also take Vancomycin, and have Neurological infection.

The phase IV clinical study analyzes which people have Encephalitis viral when taking Ceftriaxone. It is created by eHealthMe based on reports of 40,872 people who have side effects when taking Ceftriaxone from the FDA, and is updated regularly.

What is Ceftriaxone?

Ceftriaxone has active ingredients of ceftriaxone sodium. It is often used in typhoid fever. eHealthMe is studying from 40,991 Ceftriaxone users. Check the latest studies of Ceftriaxone.

What is Encephalitis viral?

Encephalitis viral (inflammation of the brain due to viral infection) is found to be associated with 147 drugs and 307 conditions by eHealthMe. Check the latest studies of Encephalitis viral.

On Jul, 26, 2026

40,872 people reported to have side effects when taking Ceftriaxone.
Among them, 21 people (0.05%) have Encephalitis viral.

Could Ceftriaxone cause Encephalitis viral?

Among these 21 people:

How long have people been on Ceftriaxone when they have Encephalitis viral? *

What is the gender of people who have Encephalitis viral when taking Ceftriaxone? *

female: 70 %
male: 30 %

What is the age of people who have Encephalitis viral when taking Ceftriaxone? *

What are other drugs people take besides Ceftriaxone? *

What are other side effects people have besides Encephalitis viral? *

Anaemia (lack of blood): 6 people, 28.57%
Malnutrition (a condition that results from eating a diet in which certain nutrients are lacking): 5 people, 23.81%
Seizures (abnormal excessive or synchronous neuronal activity in the brain): 5 people, 23.81%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 4 people, 19.05%
Bronchial Oedema (build-up of fluid in the bronchia): 4 people, 19.05%
Urinary Tract Infection: 4 people, 19.05%
Bacteraemia (presence of bacteria in the blood): 4 people, 19.05%
Appetite - Decreased (decreased appetite occurs when you have a reduced desire to eat): 4 people, 19.05%
Adenovirus Infection: 4 people, 19.05%
Acute Lymphocytic Leukemia (All) (cancer of the white blood cells characterized by excess lymphoblasts): 3 people, 14.29%

What are the existing conditions these people have? *

Neurological Infection (infection of nervous system): 10 people, 47.62%
Cytokine Release Syndrome (immediate complication occurring with the use of anti-t cell antibody infusions): 4 people, 19.05%
Urinary Tract Infection: 4 people, 19.05%
Gastroenteritis (inflammation of stomach and intestine): 4 people, 19.05%
Bacteraemia (presence of bacteria in the blood): 4 people, 19.05%
Paraesthesia (sensation of tingling, tickling, prickling, pricking, or burning of a person's skin with no apparent long-term physical effect): 3 people, 14.29%
Cytomegalovirus Infection: 3 people, 14.29%
Pressure Ulcer: 3 people, 14.29%
Pulmonary Oedema (fluid accumulation in the lungs): 3 people, 14.29%
Neuropathy Peripheral (surface nerve damage): 3 people, 14.29%

* Approximation only. Some reports may have incomplete information.

Do you take Ceftriaxone and have Encephalitis viral?

- Check whether Encephalitis viral is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Ceftriaxone:

Ceftriaxone (40,991 reports)

Browse all side effects of Ceftriaxone:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Encephalitis viral:

Encephalitis viral (147 drugs)

Browse all the conditions that are associated with Encephalitis viral:

Encephalitis viral (307 conditions)

Related publications that referenced our studies

Agrawal SR, Rajput A, Jain AP, "Leukocytoclastic vasculitis and acute allergic interstitial nephritis following ceftriaxone exposure", Journal of pharmacology & pharmacotherapeutics, 2014 Jan .
Agrawal SR, Rajput A, Jain AP, "Leukocytoclastic vasculitis and acute allergic interstitial nephritis following ceftriaxone exposure", Journal of pharmacology & pharmacotherapeutics, 2014 Jan .

How the study uses the data?

The study uses data from the FDA. It is based on ceftriaxone sodium (the active ingredients of Ceftriaxone) and Ceftriaxone (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.